Abstract
The European Respiratory Society Annual Congress 2021 took place virtually for the second year running due to the coronavirus pandemic. The congress programme featured more than 400 sessions and 3000 abstract presentations, covering the entire respiratory science and medicine field. In this article, Early Career Members of the Respiratory Infections Assembly summarise a selection of sessions across a broad range of topics, including presentations on bronchiectasis, non-tuberculosis mycobacteria, tuberculosis, cystic fibrosis and COVID-19.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Melissa J. McDonnell reports receiving Consulting fees by Bayer Pharmaceuticals for Bronchiectasis Legacy Programme. Honoraria received for lectures given at international events, no further details provided. Travel grants received from the Irish Thoracic Society and Newcastle University for attendance at European Respiratory Society Meetings. All disclosures made outside the submitted work.
Michael Loebinger reports receiving consulting fees from Insmed, Parion, Astra Zeneca, Grifols and Armata. Personal payments received for lectures, presentations, speakers bureaus, manuscript writing or educational events from Insmed and Grifols. Participation on a Data Safety Monitoring Board or Advisory Board for Redhill, Biontech, SAB and Sage. The author also repots to be ERS Group Chair. All disclosures made outside the submitted work.
Katie Leanne Horton reports receiving grants or contracts from National Institute for Health Research Biomedical Research Centre and Wessex Medical Research joint PhD studentship. Member of the advisory board for Better Experimental Approaches to Treat PCD, European Respiratory Society Clinical Research Collaboration. All disclosures made outside the submitted work.
Lidia Perea reports receiving grants or contracts from ERS Long-term Research Fellowship, outside the submitted work.
The remaining authors have nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received November 16, 2021.
- Accepted January 12, 2022.
- Copyright ©The authors 2022
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org